Clincosm LogoSign in Get a demo

Using Video Images to Improve Advance Care Planning in Patients With Cancer

Sponsor
Massachusetts General Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT00970125
Collaborator
(none)
80
Enrollment
1
Location
1
Arm
22
Duration (Months)
3.6
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

The purpose of this study is to study whether preferences for the goals of care for 80 subjects with end-stage cancer are altered after viewing a video outlining the goals of care compared to their initial preferences after hearing a verbal description of the goals of care alone.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: video
 N/A

Detailed Description

The purpose of this study is to study whether preferences for the goals of care for 80 subjects with end-stage cancer are altered after viewing a video outlining the goals of care compared to their initial preferences after hearing a verbal description of the goals of care alone. Subjects will choose among three goals of care, life prolonging care, basic medical care, and comfort care.

Study Design

Study Type:
Interventional
Actual Enrollment :
80 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Health Services Research
Official Title:
Using Video Images to Improve Advance Care Planning in Patients With Cancer
Study Start Date :
Aug 1, 2009
Actual Primary Completion Date :
Jun 1, 2011
Actual Study Completion Date :
Jun 1, 2011

Arms and Interventions

Arm Intervention/Treatment
Experimental: Cancer subjects

Behavioral: video
outline of the goals of care

Outcome Measures

Primary Outcome Measures

  1. end of life preference at time of interview [5 minutes after survey]

Secondary Outcome Measures

  1. knowledge [5 minutes after survey]

  2. decisional conflict [5 minutes after survey]

Eligibility Criteria

Criteria

Ages Eligible for Study:
21 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. Terminal, progressive cancer with poor prognosis whose treatment intent is palliative, based on the following definition:

  • All patients with brain cancer, liver cancer, inoperable non-small cell lung carcinoma, pancreatic cancer, or gallbladder cancer; OR

  • Patients with the following cancers: metastatic colon cancer or stage III or IV non-small cell lung cancer; OR

  • Patients with the following cancers, if first-line therapy has failed and limited response is expected to second-line therapy: breast cancer, colorectal cancer, head and neck cancer, stomach cancer, esophageal cancer, melanoma, leukemia, ovarian cancer, prostate cancer, renal cancer, sarcoma, lung cancer, myeloma, or lymphoma.

  • The terms terminal, progressive, poor prognosis, palliative intent and limited response will be judged by the patient's oncologist (and not by the RSA or consenting professional).

  1. Return patient visit (defined as a patient known to the oncologist from previous assessments and treatments, where the working and personal relationship has been established and not a new patient to the clinic).

  2. English speaking. Only English-speaking patients will be included in our present study since English is the validated language of our study tools.

  3. Given the sensitive nature of the study, clinicians will decide whether the patient is a potentially appropriate subject based on their knowledge of the patient.

  4. Able to provide informed consent.

  5. Age greater than or equal to 21.

Exclusion Criteria:

  1. MMSE < 25.

  2. Psychological state not appropriate for end-of-life discussion as determined by the treating clinician.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Memorial Sloan Kettering New York New York United States 10065

Sponsors and Collaborators

  • Massachusetts General Hospital

Investigators

  • Principal Investigator: Angelo E. Volandes, MD, MPH, Massachusetts General Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Angelo E. Volandes, MD, Faculty, Massachusetts General Hospital
ClinicalTrials.gov Identifier:
NCT00970125
Other Study ID Numbers:
  • 2008-P-002156/2
  • R21CA139121-01
First Posted:
Sep 2, 2009
Last Update Posted:
May 1, 2012
Last Verified:
Apr 1, 2012
Keywords provided by Angelo E. Volandes, MD, Faculty, Massachusetts General Hospital
advance care planning
cancer

Study Results

No Results Posted as of May 1, 2012